Detailed information for compound 172488

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 363.496 | Formula: C23H29N3O
  • H donors: 0 H acceptors: 1 LogP: 3.49 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccc(cc1)CN1CCN(CC1)CC(=O)N1[C@H](C)Cc2c1cccc2
  • InChi: 1S/C23H29N3O/c1-18-7-9-20(10-8-18)16-24-11-13-25(14-12-24)17-23(27)26-19(2)15-21-5-3-4-6-22(21)26/h3-10,19H,11-17H2,1-2H3/t19-/m1/s1
  • InChiKey: BKDQVRCFIJMWOR-LJQANCHMSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens solute carrier family 6 (neurotransmitter transporter), member 4 Starlite/ChEMBL References
Homo sapiens adrenoceptor alpha 1D References
Homo sapiens dopamine receptor D2 Starlite/ChEMBL References
Rattus norvegicus Delta opioid receptor Starlite/ChEMBL References
Homo sapiens adrenoceptor alpha 1A Starlite/ChEMBL References
Homo sapiens dopamine receptor D4 Starlite/ChEMBL References
Homo sapiens adrenoceptor alpha 1B References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus tm gpcr rhodopsin Get druggable targets OG5_139759 All targets in OG5_139759
Loa Loa (eye worm) norepinephrine transporter Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma japonicum ko:K04135 adrenergic receptor, alpha 1a, putative Get druggable targets OG5_128924 All targets in OG5_128924
Schistosoma japonicum ko:K05336 solute carrier family 6 (neurotransmitter transporter), invertebrate, putative Get druggable targets OG5_128364 All targets in OG5_128364
Brugia malayi Sodium:neurotransmitter symporter family protein Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma japonicum Sodium-dependent dopamine transporter, putative Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma japonicum Sodium-dependent dopamine transporter, putative Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma japonicum Alpha-1D adrenergic receptor, putative Get druggable targets OG5_128924 All targets in OG5_128924
Loa Loa (eye worm) serotonin transporter b Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma japonicum Sodium-dependent dopamine transporter, putative Get druggable targets OG5_128364 All targets in OG5_128364
Echinococcus multilocularis tm gpcr rhodopsin gpcr rhodopsin superfamily Get druggable targets OG5_139759 All targets in OG5_139759
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_128364 All targets in OG5_128364
Loa Loa (eye worm) solute carrier family 6 member 4 Get druggable targets OG5_128364 All targets in OG5_128364
Echinococcus granulosus serotonin transporter Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma japonicum Sodium-dependent dopamine transporter, putative Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma japonicum Sodium-dependent noradrenaline transporter, putative Get druggable targets OG5_128364 All targets in OG5_128364
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_128364 All targets in OG5_128364
Treponema pallidum sodium- and chloride- dependent transporter Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma mansoni sodium/chloride dependent transporter Get druggable targets OG5_128364 All targets in OG5_128364
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma japonicum Sodium-dependent dopamine transporter, putative Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma mansoni amine GPCR Get druggable targets OG5_128924 All targets in OG5_128924
Schistosoma mansoni norepinephrine/norepinephrine transporter Get druggable targets OG5_128364 All targets in OG5_128364
Onchocerca volvulus Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma japonicum Sodium-dependent dopamine transporter, putative Get druggable targets OG5_128364 All targets in OG5_128364
Echinococcus multilocularis serotonin transporter Get druggable targets OG5_128364 All targets in OG5_128364
Schistosoma japonicum IPR000175,Sodium:neurotransmitter symporter,domain-containing Get druggable targets OG5_128364 All targets in OG5_128364

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Onchocerca volvulus Delta opioid receptor   372 aa 353 aa 21.0 %
Onchocerca volvulus Delta opioid receptor   372 aa 349 aa 22.1 %
Schistosoma mansoni peptide (FMRFamide/somatostatin)-like receptor Delta opioid receptor   372 aa 366 aa 22.7 %
Echinococcus granulosus thyrotropin releasing hormone receptor Delta opioid receptor   372 aa 330 aa 24.5 %
Echinococcus multilocularis allatostatin A receptor Delta opioid receptor   372 aa 302 aa 28.5 %
Echinococcus multilocularis thyrotropin releasing hormone receptor Delta opioid receptor   372 aa 330 aa 24.2 %
Brugia malayi Sodium:neurotransmitter symporter family protein solute carrier family 6 (neurotransmitter transporter), member 4 630 aa 574 aa 31.5 %
Brugia malayi GnHR receptor homolog Delta opioid receptor   372 aa 313 aa 18.5 %
Schistosoma japonicum ko:K04134 cholinergic receptor, invertebrate, putative Delta opioid receptor   372 aa 320 aa 25.6 %
Onchocerca volvulus Delta opioid receptor   372 aa 386 aa 22.8 %
Brugia malayi ORL1-like opioid receptor Delta opioid receptor   372 aa 300 aa 24.7 %
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Delta opioid receptor   372 aa 315 aa 28.6 %
Echinococcus granulosus allatostatin A receptor Delta opioid receptor   372 aa 302 aa 27.8 %
Onchocerca volvulus Delta opioid receptor   372 aa 316 aa 26.9 %
Loa Loa (eye worm) neuropeptide F receptor Delta opioid receptor   372 aa 317 aa 23.3 %
Schistosoma mansoni peptide (allatostatin)-like receptor Delta opioid receptor   372 aa 353 aa 29.2 %
Onchocerca volvulus Delta opioid receptor   372 aa 344 aa 22.1 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis bromodomain-containing protein, putative 0.4216 0.5985 0.5939
Schistosoma mansoni hypothetical protein 0.0488 0.0112 0.0112
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Schistosoma mansoni CREB-binding protein 2 0.2827 0.3796 0.3796
Schistosoma mansoni fatty-acid amide hydrolase 0.1079 0.1043 0.1043
Trypanosoma brucei Bromodomain, putative 0.0488 0.0112 0.5
Echinococcus granulosus fatty acid amide hydrolase 1 0.1079 0.1043 0.0942
Schistosoma mansoni phd finger protein 0.0488 0.0112 0.0112
Trypanosoma brucei Bromodomain, putative 0.0488 0.0112 0.5
Trypanosoma cruzi Bromodomain, putative 0.0488 0.0112 0.5
Schistosoma mansoni hypothetical protein 0.0488 0.0112 0.0112
Leishmania major DNA-binding protein, putative,predicted bromodomain protein 0.0488 0.0112 0.5
Echinococcus multilocularis Bromodomain containing protein 0.3037 0.4127 0.4061
Schistosoma mansoni amidase 0.1079 0.1043 0.1043
Trypanosoma cruzi Bromodomain, putative 0.0488 0.0112 0.5
Trypanosoma cruzi Bromodomain, putative 0.0488 0.0112 0.5
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Echinococcus multilocularis fatty acid amide hydrolase 1 0.1079 0.1043 0.0942
Trichomonas vaginalis bromodomain-containing protein 4, brd4, putative 0.3037 0.4127 0.4061
Schistosoma mansoni bromodomain-containing protein 3 brd3 0.6764 1 1
Chlamydia trachomatis chorismate synthase 0.29 0.3912 0.5
Trichomonas vaginalis bromodomain-containing protein, putative 0.4216 0.5985 0.5939
Schistosoma mansoni bromodomain containing protein 0.0488 0.0112 0.0112
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis conserved hypothetical protein 0.3037 0.4127 0.4061
Plasmodium vivax chorismate synthase 0.29 0.3912 1
Trypanosoma brucei AAA ATPase, putative 0.0488 0.0112 0.5
Trypanosoma cruzi Bromodomain, putative 0.0488 0.0112 0.5
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis bromodomain-containing protein, putative 0.6764 1 1
Schistosoma mansoni zinc finger protein 0.0488 0.0112 0.0112
Schistosoma mansoni hypothetical protein 0.0488 0.0112 0.0112
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Brugia malayi TAZ zinc finger family protein 0.2827 0.3796 0.3726
Echinococcus granulosus CREB binding protein 0.1915 0.2359 0.2273
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Schistosoma mansoni bromodomain containing 0.0488 0.0112 0.0112
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Toxoplasma gondii bromodomain-containing protein 0.3037 0.4127 1
Trypanosoma cruzi Bromodomain factor 1 0.0488 0.0112 0.5
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trypanosoma brucei Bromodomain factor 1 0.0488 0.0112 0.5
Loa Loa (eye worm) hypothetical protein 0.1079 0.1043 0.0942
Schistosoma mansoni hypothetical protein 0.0488 0.0112 0.0112
Brugia malayi amidase 0.1079 0.1043 0.0942
Schistosoma mansoni polybromo-1 0.0488 0.0112 0.0112
Trypanosoma cruzi bromodomain-containing protein 3 0.0488 0.0112 0.5
Plasmodium falciparum chorismate synthase 0.29 0.3912 1
Trypanosoma cruzi hypothetical protein, conserved 0.0488 0.0112 0.5
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Entamoeba histolytica bromodomain-containing protein 0.3037 0.4127 1
Schistosoma mansoni bromodomain containing protein 0.0488 0.0112 0.0112
Trypanosoma brucei Bromodomain, putative 0.0488 0.0112 0.5
Onchocerca volvulus 0.3037 0.4127 1
Entamoeba histolytica bromodomain-containing protein 0.3037 0.4127 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Loa Loa (eye worm) CBP-B 0.21 0.2651 0.2567
Leishmania major hypothetical protein, conserved 0.0488 0.0112 0.5
Echinococcus granulosus bromodomain containing 2 0.6764 1 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis conserved hypothetical protein 0.4216 0.5985 0.5939
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Brugia malayi Bromodomain containing protein 0.6764 1 1
Mycobacterium tuberculosis Probable chorismate synthase AroF (5-enolpyruvylshikimate-3-phosphate phospholyase) 0.143 0.1596 0.5
Trichomonas vaginalis bromodomain containing protein, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis bromodomain-containing protein, putative 0.6764 1 1
Schistosoma mansoni transcription initiation factor tfiid 0.0488 0.0112 0.0112
Schistosoma mansoni helicase 0.0488 0.0112 0.0112
Leishmania major hypothetical protein, conserved 0.0488 0.0112 0.5
Toxoplasma gondii chorismate synthase, putative 0.29 0.3912 0.9463
Brugia malayi hypothetical protein 0.2548 0.3358 0.3282
Schistosoma mansoni CREB-binding protein 1 (SmCBP1) 0.2827 0.3796 0.3796
Trypanosoma cruzi Bromodomain, putative 0.0488 0.0112 0.5
Entamoeba histolytica bromodomain-containing protein 0.3037 0.4127 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis conserved hypothetical protein 0.3727 0.5215 0.5161
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Loa Loa (eye worm) hypothetical protein 0.1117 0.1103 0.1002
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Echinococcus multilocularis CREB binding protein 0.2079 0.2618 0.2534
Echinococcus multilocularis tm gpcr rhodopsin gpcr rhodopsin superfamily 0.0642 0.0355 0.0245
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 0.0488 0.0112 0.0112
Echinococcus multilocularis fatty acid amide hydrolase 1 0.1079 0.1043 0.0942
Trichomonas vaginalis bromodomain containing protein, putative 0.4216 0.5985 0.5939
Echinococcus multilocularis bromodomain containing 2 0.6764 1 1
Leishmania major hypothetical protein, conserved,predicted bromodomain protein 0.0488 0.0112 0.5
Echinococcus granulosus tm gpcr rhodopsin 0.0642 0.0355 0.0245
Trichomonas vaginalis bromodomain-containing protein, putative 0.4216 0.5985 0.5939
Trichomonas vaginalis histone acetyltransferase gcn5, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Loa Loa (eye worm) hypothetical protein 0.6764 1 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trypanosoma brucei bromodomain factor 2 protein, putative 0.0488 0.0112 0.5
Giardia lamblia Kinase, putative 0.3037 0.4127 1
Loa Loa (eye worm) bromodomain containing protein 0.3037 0.4127 0.4061
Mycobacterium leprae Chorismate synthase AroF (5-enolpyruvylshikimate-3-phosphate phospholyase). 0.143 0.1596 0.5
Echinococcus granulosus CREB binding protein 0.2827 0.3796 0.3726
Trypanosoma cruzi bromodomain factor 2 protein 0.0488 0.0112 0.5
Echinococcus granulosus fatty acid amide hydrolase 1 0.1079 0.1043 0.0942
Schistosoma mansoni bromodomain containing protein 0.0488 0.0112 0.0112
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Mycobacterium ulcerans chorismate synthase 0.29 0.3912 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 2 nM Inhibitory concentration against dopamine receptor D4 ChEMBL. 16220969
IC50 (binding) = 113 nM Inhibitory concentration against dopamine receptor D2 ChEMBL. 16220969
IC50 (binding) = 1118 nM Inhibitory concentration against alpha adrenergic receptor ChEMBL. 16220969
Ki (binding) = 2 nM Binding affinity towards Dopamine receptor D4 was determined via standard competitive displacement assays using [3H]-YM 09151 as the competitive ligand ChEMBL. 12372513
Ki (binding) = 113 nM Binding affinity towards Dopamine receptor D2 was determined via standard competitive displacement assays using [3H]-YM 09151 as the competitive ligand ChEMBL. 12372513
Ki (binding) = 532 nM Compound was evaluated for its inhibitory activity against the Serotonin transporter ChEMBL. 12372513
Ki (binding) = 532 nM Compound was evaluated for its inhibitory activity against the Serotonin transporter ChEMBL. 12372513
Ki (binding) = 976 nM Compound was evaluated for its inhibitory activity against the Opioid receptor delta 1 ChEMBL. 12372513
Ki (binding) = 976 nM Compound was evaluated for its inhibitory activity against the Opioid receptor delta 1 ChEMBL. 12372513
Ki (binding) = 2 uM Binding affinity towards Dopamine receptor D4 was determined via standard competitive displacement assays using [3H]-YM 09151 as the competitive ligand ChEMBL. 12372513
Ki (binding) = 113 uM Binding affinity towards Dopamine receptor D2 was determined via standard competitive displacement assays using [3H]-YM 09151 as the competitive ligand ChEMBL. 12372513
Ki (binding) = 1118 uM Binding affinity towards Alpha-1 adrenergic receptor was determined by competitive displacement assays using rat brain homogenate with [3H]-prazosin as the competitive ligand ChEMBL. 12372513
Ki (binding) = 1118 uM Binding affinity towards Alpha-1 adrenergic receptor was determined by competitive displacement assays using rat brain homogenate with [3H]-prazosin as the competitive ligand ChEMBL. 12372513
MED (functional) > 4 mg kg-1 Minimum effective dose of the compound required for significant dose dependent reduction of amphetamine-induced locomotor activity in male Sprague-Dawley rats on subcutaneous administration (30 min prior to receiving amphetamine 0.5 mg/kg) ChEMBL. 12372513

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

2 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.